Delivery Order SPE2DB24D2205-SPE2DB24FDVVP
Award Date
6/20/24
Potential Completion Date
6/21/24
Potential Value
$1.1K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of the pharmaceutical product XULANE 150-35 MCG/DAY PATCH 3S to the Defense Logistics Agency (DLA), a defense agency. The contract, valued at $1,478.97, was awarded to Amerisourcebergen Drug Corp, a major supplier of pharmaceutical products and medical supplies to the U.S. federal government. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of June 18, 2024. Amerisourcebergen Drug Corp...
This federal contract award is for the delivery of the pharmaceutical product XULANE (150-35 MCG/DAY PATCH 3S) to the Defense Logistics Agency (DLA), a defense agency. The contract was awarded to the corporate office division of Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for a ceiling value of $2,604.26. The contract has an ultimate completion date of May 22, 2024 and is a firm fixed-price delivery order with no set-aside designation. Amerisourcebergen holds a larger...
This federal contract award is for the delivery of XULANE 150-35 MCG/DAY PATCH 3S pharmaceutical products to the Defense Logistics Agency (DLA). The $1,019.04 firm fixed-price delivery order was issued to Amerisourcebergen Drug Corp, a major supplier of pharmaceuticals and medical supplies to the U.S. government, through its Corporate Office division. Amerisourcebergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary...
This federal contract award is for the delivery of the pharmaceutical product XULANE 150-35 MCG/DAY PATCH 3S to the Defense Logistics Agency (DLA). The $13,565.21 firm fixed price contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., on April 11, 2022. The contract does not have a set-aside designation, indicating full and open competition. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award is for the delivery of pharmaceutical products, specifically XULANE 150-35 MCG/DAY PATCH 3S, to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price of $2,224.18 and has an Ultimate Completion Date of February 13, 2025. This award is not associated with a set-aside designation, indicating open...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,169.82 firm fixed-price delivery order is for the supply of XULANE 150-35 MCG/DAY PATCH 3S, a medical product. The contract has an ultimate completion date of October 22, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,240.14 firm fixed-price delivery order is for the supply of "XULANE 150-35 MCG/DAY PATCH 3S", a prescription medication. This contract award is associated with Amerisourcebergen's $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of the pharmaceutical product "XULANE 150-35 MCG/DAY PATCH 3S" to the Defense Logistics Agency (DLA), a defense agency. The $1,192.24 firm fixed-price delivery order contract has a completion date of May 7, 2024. Amerisourcebergen, a large pharmaceutical distribution company, holds a single-award Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 with the DLA Troop...
This federal contract award is for the delivery of XULANE 150-35 MCG/DAY PATCH 3S pharmaceutical products to the Defense Logistics Agency (DLA), a component of the Department of Defense (DoD). The award, valued at $2,375.10, was made to Amerisourcebergen Drug Corp's Corporate Office Division, a major supplier of pharmaceutical products and medical supplies to the U.S. federal government. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen with...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $3,441.01 delivery order is for the pharmaceutical product "XULANE 150-35 MCG/DAY PATCH 3S" and has an ultimate completion date of January 18, 2022. Amerisourcebergen holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to deliver a...